ERIC S. LEDERER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sonnet BioTherapeutics Holdings, Inc.

Filing Date Source Excerpt
2014-01-21 The Summary Compensation Table lists "Eric S. Lederer ... 2012 ... Total $80,000" and footnote (2) states "Chief Financial Officer of the Company since June 2012." He is also listed among the directors in the beneficial ownership table.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09